EE156 Public Health Impact and Cost-Effectiveness of Empagliflozin (JARDIANCE®) in the Treatment of Patients with Heart Failure (HF) with Preserved Ejection Fraction (HFPEF) in France, Based on Emperor-Preserved Clinical Trial
| العنوان: | EE156 Public Health Impact and Cost-Effectiveness of Empagliflozin (JARDIANCE®) in the Treatment of Patients with Heart Failure (HF) with Preserved Ejection Fraction (HFPEF) in France, Based on Emperor-Preserved Clinical Trial |
|---|---|
| المؤلفون: | P Levy, N Lamblin, H Groyer, J Chollet, J Tardu, S Linden, L Fauchier |
| المصدر: | Value in Health. 25:S83 |
| بيانات النشر: | Elsevier BV, 2022. |
| سنة النشر: | 2022 |
| مصطلحات موضوعية: | Health Policy, Public Health, Environmental and Occupational Health |
| تدمد: | 1098-3015 |
| DOI: | 10.1016/j.jval.2022.09.406 |
| URL الوصول: | https://explore.openaire.eu/search/publication?articleId=doi_________::d96b3f384e5f8ff55c40b56a70a9c027 https://doi.org/10.1016/j.jval.2022.09.406 |
| Rights: | CLOSED |
| رقم الانضمام: | edsair.doi...........d96b3f384e5f8ff55c40b56a70a9c027 |
| قاعدة البيانات: | OpenAIRE |
كن أول من يترك تعليقا!